FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2895788492> ?p ?o ?g. }

• W2895788492 endingPage "3952" @default.
• W2895788492 startingPage "3943" @default.
• W2895788492 abstract "Primary breast diffuse large B‐cell lymphoma ( PB ‐ DLBCL ) is a rare subtype of DLBCL with limited data on patterns of failure. This multicenter study aimed to define the optimum treatment strategy and patterns of failure for PB ‐ DLBCL patients. We retrospectively reviewed data on 108 PB ‐ DLBCL patients from 21 Chinese medical centers. Only patients with localized disease (involvement of breast and localized lymph nodes) were included. After a median follow‐up of 3.2 years, 32% of patients developed progression or relapse. A continuous pattern of relapse was observed, characterized by frequent late relapses in the contralateral breast and central nervous system ( CNS ). Although rituximab significantly reduced the overall cumulative risk of progression or relapse (5‐year cumulative risk 57% vs 24%, P = .029), it had limited effect on the reduction of breast relapse ( P = .46). Consolidative radiotherapy significantly decreased the risk of breast relapse, even in the subgroup of patients treated with rituximab (5‐year cumulative risk 21.2% vs 0%, P = .012). A continuous risk of CNS progression or relapse up to 8.2 years from diagnosis was observed (10‐year cumulative risk 28.3%), with a median time to CNS relapse of 3.1 years. Neither rituximab nor prophylactic intrathecal chemotherapy significantly decreased the risk of CNS relapse. In summary, our study indicates that PB ‐ DLBCL has a continuous pattern of relapse, especially with frequent late relapses in the CNS and contralateral breast. Rituximab and RT confer complementary benefit in the reduction of relapse. However, neither the addition of rituximab nor prophylactic intrathecal chemotherapy could effectively prevent CNS relapse for PB ‐ DLBCL patients." @default.
• W2895788492 created "2018-10-26" @default.
• W2895788492 creator A5001104633 @default.
• W2895788492 creator A5006621752 @default.
• W2895788492 creator A5014399133 @default.
• W2895788492 creator A5016883560 @default.
• W2895788492 creator A5017450107 @default.
• W2895788492 creator A5018083369 @default.
• W2895788492 creator A5023513530 @default.
• W2895788492 creator A5023857412 @default.
• W2895788492 creator A5032162374 @default.
• W2895788492 creator A5033357406 @default.
• W2895788492 creator A5034031384 @default.
• W2895788492 creator A5037498466 @default.
• W2895788492 creator A5049637590 @default.
• W2895788492 creator A5050309279 @default.
• W2895788492 creator A5050495630 @default.
• W2895788492 creator A5053708169 @default.
• W2895788492 creator A5061265927 @default.
• W2895788492 creator A5063998429 @default.
• W2895788492 creator A5068949602 @default.
• W2895788492 creator A5069197516 @default.
• W2895788492 creator A5069604153 @default.
• W2895788492 creator A5069785333 @default.
• W2895788492 creator A5076036955 @default.
• W2895788492 creator A5077970092 @default.
• W2895788492 creator A5080553382 @default.
• W2895788492 creator A5086758549 @default.
• W2895788492 creator A5087025928 @default.
• W2895788492 creator A5090866405 @default.
• W2895788492 date "2018-11-11" @default.
• W2895788492 modified "2023-10-13" @default.
• W2895788492 title "Primary breast diffuse large B‐cell lymphoma in the rituximab era: Therapeutic strategies and patterns of failure" @default.
• W2895788492 cites W1604095214 @default.
• W2895788492 cites W1887228174 @default.
• W2895788492 cites W1955256573 @default.
• W2895788492 cites W1971211622 @default.
• W2895788492 cites W1979420066 @default.
• W2895788492 cites W1982274007 @default.
• W2895788492 cites W1983788860 @default.
• W2895788492 cites W1991490502 @default.
• W2895788492 cites W1995939575 @default.
• W2895788492 cites W2001238458 @default.
• W2895788492 cites W2018071905 @default.
• W2895788492 cites W2027668298 @default.
• W2895788492 cites W2034562048 @default.
• W2895788492 cites W2038981426 @default.
• W2895788492 cites W2051613520 @default.
• W2895788492 cites W2059762808 @default.
• W2895788492 cites W2062834694 @default.
• W2895788492 cites W2082037916 @default.
• W2895788492 cites W2096047333 @default.
• W2895788492 cites W2098768484 @default.
• W2895788492 cites W2100367991 @default.
• W2895788492 cites W2107246940 @default.
• W2895788492 cites W2118192033 @default.
• W2895788492 cites W2126778627 @default.
• W2895788492 cites W2131934389 @default.
• W2895788492 cites W2137572720 @default.
• W2895788492 cites W2145453495 @default.
• W2895788492 cites W2147686446 @default.
• W2895788492 cites W2157695092 @default.
• W2895788492 cites W2158267770 @default.
• W2895788492 cites W2167425679 @default.
• W2895788492 cites W2462981464 @default.
• W2895788492 cites W2660677492 @default.
• W2895788492 cites W2734666624 @default.
• W2895788492 cites W2766567226 @default.
• W2895788492 doi "https://doi.org/10.1111/cas.13828" @default.
• W2895788492 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6272095" @default.
• W2895788492 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30302857" @default.
• W2895788492 hasPublicationYear "2018" @default.
• W2895788492 type Work @default.
• W2895788492 sameAs 2895788492 @default.
• W2895788492 citedByCount "20" @default.
• W2895788492 countsByYear W28957884922019 @default.
• W2895788492 countsByYear W28957884922020 @default.
• W2895788492 countsByYear W28957884922021 @default.
• W2895788492 countsByYear W28957884922022 @default.
• W2895788492 countsByYear W28957884922023 @default.
• W2895788492 crossrefType "journal-article" @default.
• W2895788492 hasAuthorship W2895788492A5001104633 @default.
• W2895788492 hasAuthorship W2895788492A5006621752 @default.
• W2895788492 hasAuthorship W2895788492A5014399133 @default.
• W2895788492 hasAuthorship W2895788492A5016883560 @default.
• W2895788492 hasAuthorship W2895788492A5017450107 @default.
• W2895788492 hasAuthorship W2895788492A5018083369 @default.
• W2895788492 hasAuthorship W2895788492A5023513530 @default.
• W2895788492 hasAuthorship W2895788492A5023857412 @default.
• W2895788492 hasAuthorship W2895788492A5032162374 @default.
• W2895788492 hasAuthorship W2895788492A5033357406 @default.
• W2895788492 hasAuthorship W2895788492A5034031384 @default.
• W2895788492 hasAuthorship W2895788492A5037498466 @default.
• W2895788492 hasAuthorship W2895788492A5049637590 @default.
• W2895788492 hasAuthorship W2895788492A5050309279 @default.
• W2895788492 hasAuthorship W2895788492A5050495630 @default.
• W2895788492 hasAuthorship W2895788492A5053708169 @default.
• W2895788492 hasAuthorship W2895788492A5061265927 @default.

• next